We have investigated the relationship between hydrolysis of phosphatidylcholine (PC) 
The ras proto-oncogenes encode guanine nucleotide-binding proteins that play central roles in signal transduction pathways in mammalian cells. A variety of studies have established that Ras proteins are activated in association with protein-tyrosine kinase receptors and are required for growth factor-induced proliferation or differentiation of a number of cell types (4, 10, 11, 25, 32, 36) . However, identification of the targets of Ras has remained an outstanding problem in understanding intracellular signal transduction pathways. Recent progress toward this goal has been made by using a dominant inhibitory ras mutant (ras N-17) (9) to identify intracellular signaling molecules that are activated downstream of Ras in response to growth factor stimulation. These candidate targets include the Raf proteinserine/threonine kinases (9, 33, 40, 45) , mitogen-activated protein (MAP) kinase (7, 20, 38, 45) , and phosphatidylcholine (PC)-specific phospholipase C (PC-PLC) (3) .
Further studies have indicated that MAP kinase lies downstream of Raf in signal transduction pathways, with Raf serving to activate a MAP kinase kinase (MEK) (6, 12, 15) . Ras-mediated activation of Raf thus initiates a protein kinase cascade leading to MAP kinase activation. However, although activation of PC hydrolysis in response to growth factor stimulation is also Ras dependent (3), the potential role of PC-derived second messengers in the Raf protein kinase pathway has not been determined.
Hydrolysis of PC is stimulated by a variety of growth factors, providing a second source of diacylglycerol in addition to that derived from hydrolysis of phosphatidylinositides (8, 26) . Because mitogen-stimulated turnover of PC persists for several hours after growth factor exposure, it is thought to be particularly important in prolonged signaling leading to long-term responses such as mitogenesis. Hydrolysis of PC is also stimulated by oncogenic Ras proteins (17, 21, 29, 44) , and treatment of quiescent fibroblasts with * Corresponding author.
exogenous PC-PLC is itself mitogenic (18) . Although hydrolysis of PC can be catalyzed by either PC-PLC or PC-PLD (8) , it appears that PC-PLC is the primary source of sustained production of diacylglycerol during the response of fibroblasts to mitogens or Ras transformation (3, 18, 21, 23, 46 (9) . The dominant negative raf mutants, and ARaf, were cloned in the pLTRraf vector (35 10 ,000 x g. Octylglucose (1%) was added to the supematant, and the sample was gently shaken at 4°C. The mixture was centrifuged for 15 min at 100,000 x g, and the supernatant was used for MEK preparation as previously described (16) .
Raf protein kinase activity. Raf-1 was immunoprecipitated from extracts of 106 NIH 3T3 or NIH(M17) cells as previously described (15) (3) . We therefore initially investigated the relationship between PC-PLC and Raf by testing whether overexpression of PC-PLC could similarly bypass the inhibitory activity of dominant negative Raf mutants. Results of a representative experiment are illustrated in Fig. 1 , and data from three independent experiments are summarized in Fig. 2 .
As previously reported (9), transfection of the dominant inhibitory ras N-17 mutant with a neomycin resistance gene inhibited the proliferation of transfected NIH 3T3 cells, as indicated by the reduction in G418-resistant transformants obtained following transfection with the pZIP RasN17 plasmid compared with the pZIPneoSV(X) vector alone. A comparable reduction in G418-resistant colonies was observed following cotransfection of pZIPneoSV(X) with plasmids directing the expression of dominant negative Raf proteins. Similar results were obtained with two different inhibitory raf mutants: the previously characterized kinasedeficient mutant Raf-301 (14) and an additional inhibitory Cotransfection with a PC-PLC expression plasmid reversed the inhibitory effect of Ras N-17, indicating that overexpression of PC-PLC could overcome the block to cell proliferation resulting from inhibition of normal Ras function (3). In contrast, cotransfection with PC-PLC failed to reverse the growth-inhibitory effects of the dominant negative Raf mutants, indicating that PC-PLC is unable to bypass the inhibition of cell proliferation resulting from interference with normal Raf activity. It thus appears that PC-PLC acts downstream of Ras, but upstream of Raf, in mitogenic signaling. Activation of Raf by treatment with exogenous PC-PLC. The possibility that PC hydrolysis serves to couple Ras to Raf activation was further investigated by analysis of Raf phosphorylation following treatment of quiescent NIH 3T3 cells with PC-PLC. Under conditions previously found to be mitogenic (3, 18) , treatment with exogenous PC-PLC purified from B. cereus induced the electrophoretic mobility shift characteristic of Raf activation (Fig. 3) . The effects of PC-PLC treatment on Raf were similar to the effects of treatment with epidermal growth factor (EGF) or the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) (Fig.  3) . These results indicated that PC hydrolysis, like mitogenic growth factors or phorbol esters, induces hyperphosphorylation characteristic of the activation of Raf protein kinase.
Activation of Raf in response to serum, EGF, and TPA is dependent upon normal Ras activity and is blocked by Ras N-17 expression (40, 45) . However, if PC-PLC acts downstream of Ras to activate Raf, one would predict that its activity would not be inhibited by expression of the dominant negative Ras mutant. We therefore investigated Raf activation in the NIH(M17) cell line compared with normal NIH 3T3 cells (Fig. 3) . As previously reported (40), induction of Ras N-17 by dexamethasone treatment blocked Raf hyperphosphorylation in response to EGF and TPA. In contrast, induction of Ras N-17 did not affect Raf hyperphosphorylation following treatment with PC-PLC.
To verify that these effects on Raf activation assessed by hyperphosphorylation coincided with Raf protein kinase activity, we assayed Raf-1 phosphorylation of MEK substrate (Fig. 4) (Fig. 5) , indicating that this compound is an effective inhibitor of growth factor-stimulated PC-PLC in NIH 3T3 cells.
As controls for the specificity of the inhibitor, we investigated the effects of D609 on other growth factor-stimulated activities which have previously been shown to be independent of Ras function, namely, the tyrosine phosphorylation and activation of PI-PLC-y and PI 3-kinase (7, 37, 38, 40, 45) . Tyrosine phosphorylation of PI-PLC-y in serum-stimulated cells was analyzed by immunoprecipitation of cell lysates with antiphosphotyrosine antibody. PI-PLC-y was detected by immunoblotting of such immunoprecipitates from serumstimulated, but not quiescent, NIH 3T3 cells (Fig. 6) . The tyrosine phosphorylation of PI-PLCy following serum stimulation was unaffected by D609 (Fig. 6 ), indicating that D609 did not inhibit receptor tyrosine kinase activity.
To determine whether D609 inhibited the intracellular activity of PI-PLC-y, we also investigated its effect on phosphatidylinositide hydrolysis following mitogenic stimulation. The formation of inositol phosphates was increased approximately fivefold in response to serum stimulation of quiescent NIH 3T3 cells (Fig. 6 ). This was unaffected by D609 addition, indicating that D609 did not detectably inhibit the intracellular activity of PI-PLC-y.
Consistent with its lack of effect on the phosphorylation and activation of PI-PLC-y, D609 also failed to inhibit tyrosine phosphorylation of PI 3-kinase, as assessed by PI 3-kinase assays of antiphosphotyrosine immunoprecipitates (Fig. 7) . Thus, consistent with findings of previous studies (30), D609 appears to inhibit PC-PLC without interfering with the activation of other signal-transducing proteins via tyrosine phosphorylation or with the hydrolysis of phosphatidylinositides catalyzed by PI-PLC.
Since D609 appeared to be a specific inhibitor of intracellular PC hydrolysis, it was then used to investigate the effect of inhibiting PC-PLC on Raf activation in response to growth factors. As illustrated in Fig. 8 , treatment of quiescent NIH 3T3 cells with D609 effectively inhibited Raf phosphorylation in response to serum, EGF, and TPA. Likewise, D609 blocked the stimulation of Raf protein kinase activity by either serum or EGF (Fig. 9) . It (13, 34) . Importantly, however, downregulation of protein kinase C by prolonged treatment with phorbol esters inhibits neither the mitogenic activity of PC-PLC (18) nor the activation of Raf by Ras (5). Therefore, if protein kinase C mediates Raf activation, a nonclassical isoform resistant to phorbol ester downregulation would have to be involved (26) . Alternatively, PC-derived diacylglycerol might activate yet another class of Raf kinase kinases.
It should also be noted that in contrast to its activity in NIH 3T3 cells, PC-PLC may not be involved in Raf activation during Ras-mediated differentiation of PC12 cells. In these cells, we have not observed reproducible stimulation of PC turnover in response to nerve growth factor, nor is Raf activation inhibited by D609 (data not shown). This might be due to technical factors, such as differences in drug permeability or phospholipid pools between the two cell types. Moreover, PC12 cells are a tumorigenic cell line in which some signaling pathways may be constitutively activated. It is also possible, however, that a different pathway serves to couple Ras to Raf during neuronal differentiation of this cell line.
Several groups have recently reported direct proteinprotein interactions between Ras and Raf, which are presumably involved in Raf activation (24, (41) (42) (43) 47) . However, the potential effect of such interactions on Raf kinase activity has not been determined. It is possible that interactions between Ras and Raf mediate the association of Raf with a signaling complex where it is then activated as a result of PC hydrolysis. Alternatively, direct Ras-Raf protein interactions and PC hydrolysis might represent independent modes of activating the Raf protein kinase.
Previous studies have indicated that Ras is required for the activation of PC-PLC, Raf, and MAP kinase in response to growth factor stimulation (3, 7, 38, 40, 45) and that MAP kinase is activated downstream of Raf (6, 12, 15) . The present results allow the placement of PC hydrolysis upstream of the Raf protein kinase cascade in a linear pathway of mitogenic signal transduction. The role of PC hydrolysis in coupling Ras to Raf further indicates that PC-PLC occupies a central position in Ras-mediated mitogenic signaling.
